0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-48.84%PremiumNov 15, 2024Expiry Date7.16Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.11Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Kanzhun Stock Discussion
$Weibo (WB.US)$
$Sound Group (SOGP.US)$
$Getty Images (GETY.US)$
$Jiayin Group (JFIN.US)$
$Hello Group (MOMO.US)$
$Perion Network (PERI.US)$
Stocks below $20.00
$Upwork (UPWK.US)$
$Tencent Music (TME.US)$
$Kanzhun (BZ.US)$
Stock below $50.00
$Fiverr International (FVRR.US)$
$Shutterstock (SSTK.US)$
$Autohome (ATHM.US)$
$Pinterest (PINS.US)$
$Yelp Inc (YELP.US)$
$JOYY (YY.US)$
$Match group (MTCH.US)$
Click here for Top Trending Posts
If all the Chinese Stocks are up in China, except Hang Seng (Hong Kong), Why are investors are so "BEARish" on Chinese Stocks listed in the United States? Any thought?
It seems like the share prices are slowly going up and I hope people did not panic sell earlier and lost money!
Chinese equities rallied last week on strong policy signals. The CSI 300 Index surged more than 15%, marking its largest weekly gain since 2008. On Monday, the last trading session before the holiday, the index soared 8.5%, with a historic trading volume, and only eight stocks declined.
The $NASDAQ Golden Dragon China (.HXC.US)$ Index jumped over 23% over five trading da...
Gap Ups
1. $Clorox (CLX.US)$ - up 4.6%
2. $Cognizant (CTSH.US)$ - up 4.1%
3. $Informatica (INFA.US)$ - up 2.8%
4. $Kanzhun (BZ.US)$ - up 2.7%
5. $Sunrun (RUN.US)$ - up 2.6%
6. $Regeneron Pharmaceuticals (REGN.US)$ - up 1.9%
7. $McKesson (MCK.US)$ - up 1.9%
8. $Curtiss-Wright (CW.US)$ - up 1.7%
9. $MercadoLibre (MELI.US)$ - up 1.5...
Gap Ups
1. $Domino's Pizza (DPZ.US)$ - up 8.7%
2. $POSCO (PKX.US)$ - up 5.2%
3. $Fresenius Medical Care (FMS.US)$ - up 4.6%
4. $Jefferies Financial (JEF.US)$ - up 3.8%
5. $STMicroelectronics (STM.US)$ - up 3.8%
6. $Kanzhun (BZ.US)$ - up 3.8%
7. $Bilibili (BILI.US)$ - up 3.7%
8. $Rio Tinto (RIO.US)$ - up 3....
No comment yet